Innate Pharma (IPHA) Appoints Jonathan Dickinson as CEO and Board Chair

Go back to Innate Pharma (IPHA) Appoints Jonathan Dickinson as CEO and Board Chair
(NASDAQ: IPHA) Delayed: 2.18 -0.36 (14.17%)
Previous Close $2.54    52 Week High
Open $2.18    52 Week Low
Day High $2.24    P/E N/A 
Day Low $2.12    EPS
Volume 105,795